Related Experiment Video
Updated: May 21, 2025
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Machine Learning and Artificial Intelligence in the Multi-Omics Approach to Gut Microbiota
Tommaso Rozera1, Edoardo Pasolli2, Nicola Segata3
1Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, UOC Gastroenterologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Medical and Surgical Sciences, UOC CEMAD Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.
Artificial intelligence and machine learning analyze complex gut microbiome data. These advanced methods help discover microbial biomarkers for disease prediction and treatment response, aiding personalized medicine.
Area of Science:
- Microbiome research
- Computational biology
- Bioinformatics
Background:
- The gut microbiome plays a crucial role in human health and disease.
- Understanding its complexity is key for diagnostic and therapeutic applications.
- Multi-omics approaches (metagenomics, metatranscriptomics, metabolomics, metaproteomics) provide detailed insights into the gut microbial ecosystem.
Purpose of the Study:
- To discuss the application of artificial intelligence (AI) and machine learning (ML) in analyzing multi-omics gut microbiome data.
- To explore the potential of AI/ML for clinical implementation in microbiome research.
- To review the current state, potential, and limitations of AI/ML in this field.
Main Methods:
- Review and discussion of existing literature on AI/ML applications in gut microbiome multi-omics.
- Analysis of how AI/ML addresses data integration challenges from multi-omics studies.
- Exploration of AI/ML's role in biomarker discovery and treatment prediction.
Main Results:
- AI and ML are increasingly used to analyze complex multi-omics microbiome data across various conditions, including chronic diseases and cancer.
- These computational tools show promise for identifying microbial biomarkers for disease classification and prediction.
- AI/ML can potentially predict patient response to treatments and optimize microbiome-modulating therapies.
Conclusions:
- AI and ML offer powerful tools for integrating and interpreting large-scale gut microbiome multi-omics data.
- These technologies hold significant potential for advancing personalized medicine through microbiome-based diagnostics and therapeutics.
- Further research is needed to fully realize the potential and address the limitations of AI/ML in microbiome science.
